Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bloodthinner
Special Reports
Fierce Biotech’s top 10 data readouts in 2022
There are a number of potential blockbuster drugs on the list, but it’s not all about revenue potential. Many are high-risk, high-reward compounds.
Phil Taylor
Dec 20, 2021 3:00am
PhaseBio shows Brilinta reversal agent can work in an emergency
Nov 15, 2021 11:31am
PhaseBio's Brilinta reversal agent wins midstage test
Nov 3, 2021 10:16am
PhaseBio taps a manufacturing partner for Brilinta-reversing med
Mar 11, 2021 9:50am
How COVID-19 could be crippled by an age-old blood thinner
Jul 20, 2020 8:30am